The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors. This study is a major step toward the ultimate goal of treating fragile X syndrome (FXS), an ...

The most comprehensive approach, illustrated in Figure 2A using the example of SSRIs ... potentially impacts numerous serotonin receptor subtypes, spanning multiple signaling processes (pre ...